Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 42.50%18.78M | -46.83%34.55M | -63.88%13.18M | 4.61%64.99M | -6.55%48.56M | 29.40%36.47M | 61.22%25.37M | -26.65%62.12M | -21.65%51.96M | -34.20%28.18M |
| Operating income | 42.50%18.78M | -46.83%34.55M | -63.88%13.18M | 4.61%64.99M | -6.55%48.56M | 29.40%36.47M | 61.22%25.37M | -26.65%62.12M | -21.65%51.96M | -34.20%28.18M |
| Cost of sales | -220.25%-6.15M | 52.42%-8.25M | 81.26%-1.92M | 32.42%-17.34M | 36.31%-12.96M | 7.67%-10.25M | -16.83%-7.58M | 34.07%-25.66M | 29.27%-20.35M | 40.81%-11.1M |
| Operating expenses | -220.25%-6.15M | 52.42%-8.25M | 81.26%-1.92M | 32.42%-17.34M | 36.31%-12.96M | 7.67%-10.25M | -16.83%-7.58M | 34.07%-25.66M | 29.27%-20.35M | 40.81%-11.1M |
| Gross profit | 12.16%12.62M | -44.80%26.3M | -57.08%11.25M | 30.68%47.65M | 12.62%35.59M | 53.50%26.22M | 92.35%17.79M | -20.35%36.46M | -15.81%31.61M | -29.06%17.08M |
| Selling expenses | 15.17%-5.18M | 3.10%-12.05M | -3.10%-6.11M | 7.77%-12.43M | -21.31%-10.54M | -5.24%-5.93M | -26.21%-2.89M | -7.54%-13.48M | 25.35%-8.69M | 31.25%-5.63M |
| Administrative expenses | -16.19%-10.09M | -5.76%-25.8M | 30.08%-8.69M | -3.55%-24.39M | -18.10%-18.21M | -21.23%-12.42M | -10.94%-5.47M | -0.85%-23.56M | 3.67%-15.42M | -1.75%-10.25M |
| Impairment and provision | ---- | ---25.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairment is provision | ---- | ---25.75M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of operating profit | -95.06%98K | 70.17%3.11M | 116.23%1.99M | -2.51%1.83M | 40.12%1.16M | 76.88%918K | -31.85%306K | -10.80%1.87M | -29.96%830K | -46.44%519K |
| Operating profit | -63.99%-2.56M | -370.31%-34.18M | -117.72%-1.56M | 874.27%12.65M | -3.85%8.01M | 410.45%8.79M | 293.25%9.73M | -89.17%1.3M | -24.84%8.33M | -74.62%1.72M |
| Financing cost | 50.00%-16K | 2.78%-1.15M | 94.76%-32K | -188.32%-1.19M | -674.11%-867K | -1,809.38%-611K | -2,350.00%-294K | -372.41%-411K | -51.35%-112K | 46.67%-32K |
| Earning before tax | -61.70%-2.57M | -408.32%-35.34M | -119.44%-1.59M | 1,192.11%11.46M | -13.09%7.14M | 383.96%8.18M | 283.23%9.44M | -92.54%887K | -25.36%8.22M | -74.87%1.69M |
| Tax | 18.72%-899K | -357.86%-5.68M | 60.20%-1.11M | 16.43%-1.24M | 25.85%-2.32M | -225.41%-2.78M | -297.03%-2.68M | 64.26%-1.49M | 29.64%-3.13M | 73.21%-854K |
| After-tax profit from continuing operations | -28.71%-3.47M | -501.35%-41.02M | -149.93%-2.7M | 1,809.03%10.22M | -5.25%4.82M | 545.93%5.4M | 278.03%6.76M | -107.73%-598K | -22.46%5.09M | -76.36%836K |
| After-tax profit from non-continuing business | 168.14%569K | ---- | ---835K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | 17.84%-2.9M | -501.35%-41.02M | -165.39%-3.53M | 1,809.03%10.22M | -5.25%4.82M | 545.93%5.4M | 278.03%6.76M | -107.73%-598K | -22.46%5.09M | -76.36%836K |
| Minority profit | ---156K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Profit attributable to shareholders | 22.26%-2.75M | -501.35%-41.02M | -165.39%-3.53M | 1,809.03%10.22M | -5.25%4.82M | 545.93%5.4M | 278.03%6.76M | -107.73%-598K | -22.46%5.09M | -76.36%836K |
| Basic earnings per share | 22.73%-0.0034 | -500.00%-0.0512 | -165.67%-0.0044 | 1,928.57%0.0128 | -6.25%0.006 | 570.00%0.0067 | 281.82%0.0084 | -107.22%-0.0007 | -21.95%0.0064 | -77.27%0.001 |
| Diluted earnings per share | 22.73%-0.0034 | -500.00%-0.0512 | -165.67%-0.0044 | 1,928.57%0.0128 | -6.25%0.006 | 570.00%0.0067 | 281.82%0.0084 | -107.22%-0.0007 | -21.95%0.0064 | -77.27%0.001 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.